|
Market Cap (24-Jun) $7,649,007 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
1AD released this announcement to the ASX on 28 April 2021, 17:24. The announcement is not marked as price sensitive, and is 26 page(s) in length and 9.97MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| CSO presentation at ILD Drug Development Summit | 28 April 2021, 17:24 |
| Quarterly Appendix 4C and Activities Report | 20 April 2021, 8:28 |
| Mutiple Dose Part Of Ad-214 Phase I Trial Commenced | 19 April 2021, 8:25 |
| Appendix 3G | 1 April 2021, 8:31 |
You must be logged in to post a reply.
AdAlta 